Thursday, October 03, 2019 10:05:42 AM
Assuming you do almost concurrent visits by the Clinical Research Associate to inspect the data at the sites, etc., you’d have only a few of the very last patients to confirm the data. And the last patient 6 months after the dose, is July so you’d have to think a PR on Top Line is right around the corner. Any bets on getting pozi topline before the Rolontis filing? Actually, I hope PRs for both are right around the corner. Here’s an excerpt paraphrasing what was said about being blinded from yesterday’s CC.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM